Return
Company Page
Vectiopep
Founders
Vectiopep is a biotechnology company developing peptide-based nucleic acid delivery technology that enables selective delivery of therapeutic mRNA to immune cells for cancer immunotherapy. The company's proprietary technology uses cell-penetrating peptides to transport mRNA therapeutics, teaching the body's immune system to recognize and fight cancer cells. Vectiopep is a University of Tartu spin-off founded by researchers with over 10 years of expertise in developing and optimizing delivery technologies for nucleic acids.
Company Founded in 2022
Healthtech & Biotech